SEC Comment Letter 0000000000-24-012770 to Instil Bio, Inc. (TIL) (CIK 0001789769) (TIL)
Instil Bio, Inc. (TIL) (CIK 0001789769)
Date: Nov. 19, 2024 · CIK: 0001789769 · Accession: 0000000000-24-012770
AI Filing Summary & Sentiment
File numbers found in text: 333-283205
Letter
November 19, 2024 Bronson Crouch Chief Executive Officer Instil Bio, Inc. 3963 Maple Avenue, Suite 350 Dallas, TX 75219 Re:Instil Bio, Inc. Registration Statement on Form S-3 Filed November 13, 2024 File No. 333-283205 Dear Bronson Crouch: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Courtney M.W. Tygesson, Esq.
Show Raw Text
November 19, 2024
Bronson Crouch
Chief Executive Officer
Instil Bio, Inc.
3963 Maple Avenue, Suite 350
Dallas, TX 75219
Re:Instil Bio, Inc.
Registration Statement on Form S-3
Filed November 13, 2024
File No. 333-283205
Dear Bronson Crouch:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Courtney M.W. Tygesson, Esq.